---
figid: PMC12245688__fonc-15-1576781-g002
figtitle: Action of HDACi on immune cells
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12245688
filename: fonc-15-1576781-g002.jpg
figlink: /pmc/articles/PMC12245688/figure/F2/
number: F2
caption: 'Mechanism of action of HDACi on immune cells. ECM: HDACi promotes ECM reduction.
  Macrophage: HDACi promotes M1 macrophage polarization and inhibits M2 macrophage
  polarization. T cell: HDACi activates the Wnt/β-catenin signaling pathway, promotes
  cytokine release, and reduces the number of Tregs. B cell: HDACi promotes the reduction
  of autoreactive B cells, maintains the number of memory B cells, and promotes apoptosis
  of malignant B cells in B-cell lymphoma. NK cell, HDACi enhances cytotoxicity and
  promotes cell proliferation. DC, HDACi inhibits the release of cytokines by dendritic
  cells and suppresses their antigen-presenting capacity by downregulating the NF-κB
  signaling pathway'
papertitle: 'Advances of HDAC inhibitors in tumor therapy: potential applications
  through immune modulation'
reftext: Jiaqi Tian, et al. Front Oncol. 2025;15(NA).
year: '2025'
doi: 10.3389/fonc.2025.1576781
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media SA
keywords: HDACi | tumor therapy | immunotherapy | tumor microenvironment | combination
  therapy
automl_pathway: 0.8972191
figid_alias: PMC12245688__F2
figtype: Figure
redirect_from: /figures/PMC12245688__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12245688__fonc-15-1576781-g002.html
  '@type': Dataset
  description: 'Mechanism of action of HDACi on immune cells. ECM: HDACi promotes
    ECM reduction. Macrophage: HDACi promotes M1 macrophage polarization and inhibits
    M2 macrophage polarization. T cell: HDACi activates the Wnt/β-catenin signaling
    pathway, promotes cytokine release, and reduces the number of Tregs. B cell: HDACi
    promotes the reduction of autoreactive B cells, maintains the number of memory
    B cells, and promotes apoptosis of malignant B cells in B-cell lymphoma. NK cell,
    HDACi enhances cytotoxicity and promotes cell proliferation. DC, HDACi inhibits
    the release of cytokines by dendritic cells and suppresses their antigen-presenting
    capacity by downregulating the NF-κB signaling pathway'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFA
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - ARG1
  - TINAGL1
  - NFKB1
  - MARK1
  - ACTA1
  - COL1A1
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - HDAC9
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - IL2
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - TNF
  - TCF4
  - TCF7L2
  - LEF1
  - CD8A
  - CD8B
  - UBE2C
  - BCL6
  - PDCD4
  - HDACI
  - HDAC Inhibitor
---
